What Is GLP-1 Therapy? A Complete Guide for Weight Loss Patients

If you've struggled with weight loss for years — trying diet after diet, exercise program after exercise program — you're not alone. Obesity is one of the most complex chronic diseases of our time, and it's not a willpower problem. It's a biology problem. That's exactly where GLP-1 therapy comes in, and why it has become one of the most significant medical breakthroughs in the treatment of obesity in decades.

In this comprehensive guide, we'll walk you through everything you need to know about GLP-1 therapy: what it is, how it works, who qualifies, what results to expect, and how Healthcare One can help you get started safely and effectively.

What Is GLP-1?

GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in your gut after you eat. It plays a critical role in regulating blood sugar, slowing digestion, and — most importantly for weight loss — signaling to your brain that you're full. In people with obesity, this hormonal signaling is often impaired, making it much harder to feel satisfied after meals.

Think of GLP-1 as your body's natural "I'm full" messenger. When it works properly, it tells your brain to stop eating, slows the movement of food through your digestive system, and helps your pancreas release the right amount of insulin. When this system is disrupted — as it often is in people with obesity — hunger becomes harder to control, and weight gain becomes easier.

How Do GLP-1 Medications Work?

GLP-1 receptor agonists are synthetic versions of this hormone that stay active in your body much longer than the natural version. While your body's natural GLP-1 breaks down within minutes, these medications remain active for days — providing sustained appetite suppression and metabolic benefits around the clock.

They work through several powerful, interconnected mechanisms:

• Appetite suppression: They signal your brain — specifically the hypothalamus — to reduce hunger and increase feelings of fullness, often dramatically reducing how much you want to eat
• Slowed gastric emptying: Food moves more slowly through your stomach, keeping you satisfied longer after each meal
• Blood sugar regulation: They stimulate insulin release in response to meals and suppress glucagon, stabilizing blood sugar and reducing energy crashes that trigger cravings
• Reduced cravings: Many patients report significantly fewer food cravings, especially for high-calorie, ultra-processed foods — an effect that goes beyond simple appetite reduction
• Central nervous system effects: Emerging research suggests GLP-1 medications also act on reward pathways in the brain, reducing the pleasure response to food and making it easier to make healthier choices

The Main GLP-1 Medications Available Today

Several GLP-1 medications are currently FDA-approved and available through Healthcare One. The two most widely used for weight management are:

Semaglutide (Ozempic / Wegovy)

Semaglutide was the first GLP-1 medication to receive FDA approval specifically for chronic weight management (as Wegovy). It's administered as a once-weekly subcutaneous injection and has an extensive body of clinical evidence behind it from the landmark STEP trial series.

• Average weight loss: 15.3% of body weight over 68 weeks in the STEP 1 trial
• Over 86% of patients achieved at least 5% weight loss
• Demonstrated cardiovascular benefits in the SELECT trial (20% reduction in major cardiovascular events)
• Well-studied with a strong long-term safety profile spanning multiple years

Tirzepatide (Mounjaro / Zepbound)

Tirzepatide is a newer, dual-action medication that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual mechanism produces even greater weight loss than GLP-1 alone, making it the most effective medication currently available for obesity treatment.

• Average weight loss: 20.9% of body weight over 72 weeks in the SURMOUNT-1 trial
• Over 50% of patients lost more than 20% of their body weight
• FDA-approved for Type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)
• Showing superior efficacy to semaglutide in head-to-head comparisons

Who Qualifies for GLP-1 Therapy?

GLP-1 medications are FDA-approved for adults who meet specific criteria. Most adults qualify if they fall into one of the following categories:

• BMI of 30 or higher — classified as obesity, regardless of other health conditions
• BMI of 27 or higher with at least one weight-related health condition, such as:
  • Type 2 diabetes or prediabetes
  • High blood pressure (hypertension)
  • High cholesterol (dyslipidemia)
  • Obstructive sleep apnea
  • Cardiovascular disease
  • Non-alcoholic fatty liver disease (NAFLD)

GLP-1 therapy is generally not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or those who are pregnant or planning to become pregnant. A Healthcare One physician will review your complete health history during your consultation to determine the best treatment plan for you.

What Results Can I Expect?

Most patients begin noticing reduced appetite within the first 1–2 weeks of starting GLP-1 therapy. This is often described as a dramatic shift — food simply becomes less interesting, portions feel satisfying at much smaller sizes, and the constant mental preoccupation with food diminishes significantly.

Here's a general timeline of what to expect:

• Weeks 1–2: Reduced appetite and food cravings begin; some patients notice early weight loss
• Weeks 4–8: Meaningful weight loss typically begins; most patients have lost 3–5% of body weight
• Months 3–6: Continued steady weight loss; energy levels often improve; metabolic markers begin improving
• Months 6–12: Significant weight loss achieved; many patients reach 10–15% of body weight lost
• Months 12–18: Maximum weight loss typically achieved; 15–22% average total body weight loss

Is GLP-1 Therapy Safe?

GLP-1 medications have been studied extensively in large, rigorous clinical trials involving tens of thousands of patients over multiple years. They are FDA-approved for chronic weight management and have a well-established safety profile.

The most common side effects are mild and gastrointestinal in nature:

• Nausea (most common, especially when starting or increasing dose)
• Constipation or diarrhea
• Mild stomach discomfort or bloating
• Reduced appetite (the intended therapeutic effect)
• Fatigue during the initial adjustment period

These side effects typically subside within a few weeks as your body adjusts to the medication. Healthcare One's gradual dose escalation protocol is specifically designed to minimize discomfort — we start you at the lowest effective dose and increase slowly over several months.

Serious side effects are rare but include pancreatitis and gallbladder disease. Your Healthcare One provider will monitor you throughout your treatment and is available through your patient portal 7 days a week to address any concerns.

GLP-1 Therapy vs. Bariatric Surgery

For many years, bariatric surgery was the only treatment that could produce the level of weight loss now achievable with GLP-1 medications. Here's how they compare:

• Weight loss: GLP-1 medications achieve 15–22% body weight loss; bariatric surgery typically achieves 25–35%
• Risk: GLP-1 medications are non-surgical with mild, manageable side effects; surgery carries procedural risks and requires recovery time
• Reversibility: GLP-1 therapy can be stopped at any time; surgery is largely permanent
• Accessibility: GLP-1 therapy is available through telehealth from home; surgery requires hospital admission
• Cost: GLP-1 therapy is significantly less expensive than surgery, especially with insurance coverage

For most patients who don't have severe obesity or urgent surgical indications, GLP-1 therapy offers a compelling, effective, and far less invasive alternative to surgery.

How to Get Started with Healthcare One

Getting started with GLP-1 therapy through Healthcare One is simple, fast, and entirely online. Here's how it works:

1. Free consultation: Complete a brief health questionnaire and schedule a video consultation with a licensed Healthcare One physician — at no cost to you
2. Medical evaluation: Your provider reviews your health history, current medications, and weight loss goals to determine if GLP-1 therapy is right for you and which medication is best
3. Prescription & delivery: If approved, your prescription is sent to a licensed pharmacy and delivered directly to your door within 3–5 business days
4. Ongoing support: Monthly check-ins with your provider, access to our patient portal 7 days a week, and a dedicated care team to support you every step of the way